Study Identifies Cetuximab Infusion Reaction Risk Factors in Japanese Cancer Patients
A retrospective multicentre study of Japanese cancer patients found a 7.8 percent cetuximab infusion reaction rate and identified head and ...
A retrospective multicentre study of Japanese cancer patients found a 7.8 percent cetuximab infusion reaction rate and identified head and ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.